To identify drivers of kinase-independent TKI resistance in CML, we performed genome-wide expression analyses on TKI-resistant versus sensitive CML cell lines, revealing a nuclear factor-kappa B (NF-κB) expression signature. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.